Clinical Trial Update: A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety, efficacy and pharmacokinetics of EYU688 in patients with dengue fever is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue

Drugs mentioned

• EYU688

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Dengue | Phase 2 | Status: RECRUITING